抄録
We report a case of human epidermal growth factor receptor (HER) 2 positive stage IV advanced gastric cancer successfully treated with chemotherapy combined with trastuzumab. A 50-year-old man was diagnosed with type 3 gastric cancer complicated by liver and lymph node metastases. Owing to a HER2 immunohistochemistry tumor score of 3+, we initiated capecitabine plus CDDP plus trastuzumab chemotherapy. After 6 chemotherapy courses, computed tomography showed the liver metastasis had disappeared and the paraaortic lymph nodes had shrunk. We continued the capecitabine plus trastuzumab chemotherapy, which resulted in a progression free survival of 31 months. After 38 chemotherapy courses, the primary tumor progressed; therefore, the patient underwent surgery. Chemotherapy combined with trastuzumab can allow for resection of the primary tumor.
| 本文言語 | English |
|---|---|
| ページ（範囲） | 1113-1116 |
| ページ数 | 4 |
| ジャーナル | Japanese Journal of Cancer and Chemotherapy |
| 巻 | 43 |
| 号 | 9 |
| 出版ステータス | Published - 2016 9月 |
| 外部発表 | はい |
ASJC Scopus subject areas
- 腫瘍学
- 癌研究
UN SDG
この成果は、次の持続可能な開発目標に貢献しています
